NCCN Guidelines (R) Insights Hepatobiliary Cancers, Version 1.2017 Featured Updates to the NCCN Guidelines

Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Saenz, DA; Are, C; Brown, DB; Chang, DT; Covey, AM; Hawkins, W; Iyer, R; Jacob, R; Karachristos, A; Kelley, RK; Kim, R; Palta, M; Park, JO; Sahai, V; Schefter, T; Schmidt, C; Sicklick,

Benson, AB (reprint author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017; 15 (5): 563

Abstract

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

Download PDF


Full Text Link